PulseAugur
EN
LIVE 05:00:54

Open-source engine and graph AI accelerate drug discovery research

A new open-source engine called Open Drug Discovery Engine (OpenDDE) has been introduced, designed to model biomolecular interactions and accelerate drug discovery. This engine integrates advances in all-atom architecture and reasoning, aiming to democratize access to advanced biomolecular intelligence. Concurrently, AWS is exploring the use of graph-powered AI, specifically Graphrag and BYOKG with Amazon Neptune Analytics, to address knowledge fragmentation in pharmaceutical research by creating interconnected knowledge graphs from disparate data sources. AI

IMPACT New tools and AI approaches aim to accelerate drug discovery by improving data integration and molecular modeling.

RANK_REASON The cluster describes the release of a new open-source engine for drug discovery and a blog post detailing the application of graph-powered AI in pharmaceutical research.

Read on arXiv cs.AI →

AI-generated summary · Google Gemini · from 2 sources. How we write summaries →

Open-source engine and graph AI accelerate drug discovery research

COVERAGE [2]

  1. arXiv cs.AI TIER_1 English(EN) · Aureka AI OpenDDE project ·

    Folding, Reasoning, and Scaling with Open-source Drug Discovery Engine

    arXiv:2607.03787v1 Announce Type: new Abstract: Accurately modeling biomolecular interactions is a central bottleneck in biology and therapeutic discovery. Here, we introduce Open Drug Discovery Engine (OpenDDE), an open-source, all-atom biomolecular foundation model that uses co…

  2. AWS Machine Learning Blog TIER_1 English(EN) · Jasmine Rasheed Syed ·

    Powering scientific discovery: BYOKG and GraphRAG for intelligent pharmaceutical research

    In this post, we explore how Graph-based Retrieval Augmented Generation (GraphRAG) is transforming scientific research by combining graph databases with generative AI. With this approach, you can accelerate discovery processes without compromising scientific integrity.